Article
Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection.
AIDS (London, England) - 13 Nov 2013
Neukam Karin, Caruz Antonio, Rivero-Juárez Antonio, Barreiro Pablo, Merino Dolores, Real Luis M, Herrero Rocío, Camacho Angela, Soriano Vicente, Di Lello Federico A, Macías Juan, Rivero Antonio, Pineda Juan A
Abstract excerpt
OBJECTIVE: To identify genetic factors that predict sustained virological response (SVR) to pegylated interferon (Peg-IFN)/ribavirin (RBV) in HIV/hepatitis C virus (HCV) genotype 1 or 4-coinfected patients and that enhance the predictive capacity of IL28B genotype in this population. DESIGN: Prospective cohort study. SETTING: Five tertiary care centers in Spain. PATIENTS: Two hundred and five HIV/HCV genotype 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
